HORIZON THERAPEUTICS PLC

Barclays PLC
12 May 2023
 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2007 (AS AMENDED)

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES

REPRESENTING 1% OR MORE

1.

KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

HORIZON THERAPEUTICS PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

$0.0001 ordinary shares

Date of dealing

11 May 2023

2.

INTERESTS AND SHORT POSITIONS

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

$0.0001 ordinary shares


Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities 

1,307,445

0.57%

517,999

0.23%

(2)

Derivatives (other than options):

53,580

0.02%

0

0.00%

(3)

Options and agreements to purchase/sell:

1,532,700

0.67%

1,379,500

0.60%

TOTAL:

2,893,725

1.27%

1,897,499

0.83%

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

(3)

Options and agreements to purchase/sell:

 

 

 

 

TOTAL:

 

 

 

 

3.

DEALINGS (Note 4)

(a)

Purchase and sales

 






Class of relevant Security

Purchase/sale

Number of securities

Price per unit

$0.0001 ordinary shares

Purchase

36

                 109.9200 USD

$0.0001 ordinary shares

Purchase

88

                 110.0592 USD

$0.0001 ordinary shares

Purchase

100

                 110.0600 USD

$0.0001 ordinary shares

Purchase

100

                 109.9070 USD

$0.0001 ordinary shares

Purchase

100

                 109.9850 USD

$0.0001 ordinary shares

Purchase

101

                 109.9846 USD

$0.0001 ordinary shares

Purchase

123

                 110.5000 USD

$0.0001 ordinary shares

Purchase

157

                 110.0300 USD

$0.0001 ordinary shares

Purchase

187

                 109.9628 USD

$0.0001 ordinary shares

Purchase

300

                 110.0007 USD

$0.0001 ordinary shares

Purchase

331

                 109.9258 USD

$0.0001 ordinary shares

Purchase

401

                 110.0040 USD

$0.0001 ordinary shares

Purchase

488

                 109.9479 USD

$0.0001 ordinary shares

Purchase

601

                 109.9354 USD

$0.0001 ordinary shares

Purchase

615

                 109.9524 USD

$0.0001 ordinary shares

Purchase

797

                 109.9399 USD

$0.0001 ordinary shares

Purchase

1,850

                 109.9312 USD

$0.0001 ordinary shares

Purchase

2,152

                 109.9481 USD

$0.0001 ordinary shares

Purchase

3,455

                 109.9794 USD

$0.0001 ordinary shares

Purchase

6,378

                 110.0216 USD

$0.0001 ordinary shares

Purchase

8,268

                 110.1332 USD

$0.0001 ordinary shares

Purchase

8,946

                 110.0150 USD

$0.0001 ordinary shares

Purchase

10,625

                 109.9300 USD

$0.0001 ordinary shares

Purchase

11,396

                 110.0048 USD

$0.0001 ordinary shares

Purchase

12,369

                 110.0477 USD

$0.0001 ordinary shares

Purchase

23,107

                 110.0230 USD

$0.0001 ordinary shares

Sale

3

                 109.9166 USD

$0.0001 ordinary shares

Sale

4

                 109.9225 USD

$0.0001 ordinary shares

Sale

5

                 110.0250 USD

$0.0001 ordinary shares

Sale

5

                 109.9540 USD

$0.0001 ordinary shares

Sale

6

                 110.0416 USD

$0.0001 ordinary shares

Sale

8

                 109.9975 USD

$0.0001 ordinary shares

Sale

8

                 110.0087 USD

$0.0001 ordinary shares

Sale

9

                 109.9966 USD

$0.0001 ordinary shares

Sale

10

                 109.9500 USD

$0.0001 ordinary shares

Sale

17

                 110.0058 USD

$0.0001 ordinary shares

Sale

32

                 109.9725 USD

$0.0001 ordinary shares

Sale

61

                 110.2854 USD

$0.0001 ordinary shares

Sale

68

                 109.9900 USD

$0.0001 ordinary shares

Sale

84

                 109.8703 USD

$0.0001 ordinary shares

Sale

93

                 110.0400 USD

$0.0001 ordinary shares

Sale

100

                 110.4100 USD

$0.0001 ordinary shares

Sale

100

                 109.9000 USD

$0.0001 ordinary shares

Sale

100

                 109.8800 USD

$0.0001 ordinary shares

Sale

132

                 109.9200 USD

$0.0001 ordinary shares

Sale

134

                 110.4614 USD

$0.0001 ordinary shares

Sale

157

                 110.0300 USD

$0.0001 ordinary shares

Sale

192

                 110.0095 USD

$0.0001 ordinary shares

Sale

200

                 110.1550 USD

$0.0001 ordinary shares

Sale

220

                 109.9018 USD

$0.0001 ordinary shares

Sale

262

                 110.0552 USD

$0.0001 ordinary shares

Sale

268

                 109.9589 USD

$0.0001 ordinary shares

Sale

403

                 110.4262 USD

$0.0001 ordinary shares

Sale

424

                 110.0349 USD

$0.0001 ordinary shares

Sale

462

                 109.9951 USD

$0.0001 ordinary shares

Sale

500

                 110.2440 USD

$0.0001 ordinary shares

Sale

500

                 110.2150 USD

$0.0001 ordinary shares

Sale

559

                 110.1839 USD

$0.0001 ordinary shares

Sale

591

                 109.9795 USD

$0.0001 ordinary shares

Sale

617

                 110.3991 USD

$0.0001 ordinary shares

Sale

698

                 110.0887 USD

$0.0001 ordinary shares

Sale

809

                 110.2895 USD

$0.0001 ordinary shares

Sale

1,612

                 110.0470 USD

$0.0001 ordinary shares

Sale

2,162

                 109.9962 USD

$0.0001 ordinary shares

Sale

2,473

                 110.1292 USD

$0.0001 ordinary shares

Sale

5,251

                 110.1457 USD

$0.0001 ordinary shares

Sale

6,184

                 110.4000 USD

$0.0001 ordinary shares

Sale

6,666

                 110.0210 USD

$0.0001 ordinary shares

Sale

9,166

                 110.0119 USD

$0.0001 ordinary shares

Sale

11,279

                 109.9988 USD

$0.0001 ordinary shares

Sale

12,369

                 110.0477 USD

$0.0001 ordinary shares

Sale

13,654

                 109.9776 USD

$0.0001 ordinary shares

Sale

21,115

                 109.9421 USD

 
















(b)

Derivatives transactions (other than option transactions)

Product Name

Nature of transaction

Number of relevant securities

Price per unit

 

 

 

 

 
















(c)

Options transactions in respect of existing securities

(i)

Writing, selling, purchasing or varying

Class

 of

 relevant

 security

Product

 description

Writing,

 purchasing,

 selling,

 varying etc

Number

 of

 securities

 to which

 option

 relates

Exercise

 price

 per unit

Type

Expiry

 date

Option

 money

 paid/

 received

 per unit

 

 

 

 

 

 

 

 

 
















(ii)

Exercising

 






Product name

Number of

 securities

Exercise price

 per unit

 

 

 

 
















(d)

Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

Details

Price per unit

 (if applicable)

 

 

 

4.

OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing

 and any other person relating to the voting rights of any relevant securities under any option

 referred to on this form or relating to the voting rights or future acquisition or disposal of any

 relevant securities to which any derivative referred to on this form is referenced. If none, this

 should be stated.

NONE

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

12 May 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

 








SUPPLEMENTAL FORM 8

 








IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL

ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as

appropriate)

OPEN POSITIONS

 







Class of relevant

 security

Product

 Description

Writing,

 purchasing,

 selling,

 varying etc

Number

 of

 securities

 to which

 option

 relates

Exercise

 price

 per unit

Type

Expiry

 date

$0.0001 ordinary shares

Put Options

Written

150,000

090

American

19 May 2023

$0.0001 ordinary shares

Put Options

Written

495,500

100

American

16 Jun 2023

$0.0001 ordinary shares

Put Options

Purchased

-65,000

095

American

19 May 2023

$0.0001 ordinary shares

Put Options

Purchased

-67,300

110

American

19 May 2023

$0.0001 ordinary shares

Put Options

Purchased

-25,000

085

American

19 May 2023

$0.0001 ordinary shares

Put Options

Purchased

-250,000

080

American

16 Jun 2023

$0.0001 ordinary shares

Put Options

Written

250,000

105

American

16 Jun 2023

$0.0001 ordinary shares

Put Options

Written

10,200

080

American

18 Aug 2023

$0.0001 ordinary shares

Put Options

Written

400,000

100

American

18 Aug 2023

$0.0001 ordinary shares

Put Options

Written

65,000

105

American

19 May 2023

$0.0001 ordinary shares

Put Options

Purchased

-800,000

080

American

18 Aug 2023

$0.0001 ordinary shares

Put Options

Written

162,000

105

American

21 Jul 2023

$0.0001 ordinary shares

Put Options

Purchased

-10,200

100

American

18 Aug 2023

$0.0001 ordinary shares

Put Options

Purchased

-162,000

090

American

21 Jul 2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Barclays (BARC)
UK 100

Latest directors dealings